Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes
- PMID: 30475835
- PMCID: PMC6261039
- DOI: 10.1371/journal.pone.0207614
Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes
Abstract
Surveillance of bovine tuberculosis (bTB) is partly based on the sanitary inspection of carcasses at the abattoir to detect bTB-like lesions which, in compliance with EU recommendations, are analysed by bacteriology and histopathology to disclose Mycobacterium bovis (or M. caprae) infection. Moreover, since 2012, a PCR method with similar sensitivity and specificity values of histopathology and bacteriology respectively is additionally employed in France, partially compensating for the weaknesses of classical diagnostic methods. We analysed a collection of bTB-like lesions from cattle presenting positive histological results albeit with negative PCR results. We present here the results of these samples, recovered from 292 animals culled between 2013 and 2016, analysed with a second line molecular diagnosis approach that consists in a combination of PCRs targeting the M. tuberculosis-M. avium complexes as well as the Mycobacterium genus and sequencing of hsp65 gene. These molecular analyses disclosed to identify the presence of non-tuberculous bacteria which could be responsible for most of these non-specific TB lesions: non tuberculous mycobacteria (24%) or Actinomycetales (56%) such as Rhodococcus equi (53%); 24% of the samples were negative. M. bovis -or any other MTBC members- was neither detected by molecular methods nor isolated in any of them at the end of the 3 months of culture. In conclusion, these results highlight the lack of specificity of histopathology and the usefulness of a first line PCR with a second line molecular diagnostic test to circumvent it. This diagnostic strategy makes it possible to reduce the number of suspect bTB cases raised at the abattoir or shortening their lock-up periods. By simplifying diagnostic schemes, the use of this tool could improve bTB surveillance and make eradication programs more efficient in the future.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Muller B, Durr S, Alonso S, Hattendorf J, Laisse CJ, Parsons SD, et al. Zoonotic Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis. 2013;19(6):899–908. 10.3201/eid1906.120543 . - DOI - PMC - PubMed
-
- Lambert S, Hars J, Réveillaud E, Moyen JL, Gares H, Rambaud T, et al. Host status of wild roe deer in bovine tuberculosis endemic areas. Eur J Wildl Res. 2017;63:15 10.1007/s10344-016-1071-4 - DOI
-
- Hauer A, De Cruz K, Cochard T, Godreuil S, Karoui C, Henault S, et al. Genetic evolution of Mycobacterium bovis causing tuberculosis in livestock and wildlife in France since 1978. PloS one. 2015;10(2):e0117103 10.1371/journal.pone.0117103 . - DOI - PMC - PubMed
-
- Schiller I, Waters WR, Vordermeier HM, Jemmi T, Welsh M, Keck N, et al. Bovine tuberculosis in Europe from the perspective of an officially tuberculosis free country: trade, surveillance and diagnostics. Vet Microbiol. 2011;151(1–2):153–9. 10.1016/j.vetmic.2011.02.039 . - DOI - PubMed
-
- Radunz B. Surveillance and risk management during the latter stages of eradication: experiences from Australia. Vet Microbiol. 2006;112(2–4):283–90. 10.1016/j.vetmic.2005.11.017 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
